For the Inventor, By the Inventor

Enter assignee name

North Ryde, Australia

Biosceptre (Aust) Pty Ltd

USPTO Granted Patents = 17

% Expired Patents = 11.8

Trademarks = 2

Forward Citations = 51

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Julian Alexander Barden (16 out of 32 patents)

Angus Gidley-Baird (10 out of 25 patents)

Philip Jones (4 out of 13 patents)

4. Neil Brewis (4 out of 5 patents)

5. Steven Grant (4 out of 20 patents)

6. Xiaojuan Gong (2 out of 3 patents)

7. Minoo Jalili Moghaddam (2 out of 14 patents)

8. Justin Taylor Coombs (1 out of 1 patent)

9. Simon Charles Barry (1 out of 1 patent)

10. Timothy John Sadlon (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 12129295 - Anti P2X7 receptor antibodies and fragments thereof (2024-10-29),

2. 12121539 - Chimeric antigen receptors and uses thereof (2024-10-22),

3. 12097265 - Cytotoxic particles for targeting P2X7 receptor (2024-09-24),

4. 11260131 - Cytotoxic particles for targeting P2X7 receptor (2022-03-01),

5. 10988532 - Anti P2Xreceptor antibodies and fragments thereof (2021-04-27),

6. 10597451 - Methods of treating cancer with a P2X7 peptide (2020-03-24),

7. 10543262 - Combination therapy utilizing P2X7 peptides (2020-01-28),

8. 10450380 - Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor (2019-10-22),

9. 10245308 - Combination therapy utilizing P2X7 peptides (2019-04-02),

10. 10238716 - [object Object] (2019-03-26),

11. 10053508 - Anti P2X7 receptor antibodies and fragments thereof (2018-08-21),

12. 9944701 - Methods of treating cancer with antibodies that bind P2X7 receptors (2018-04-17),

13. 9688771 - [object Object] (2017-06-27),

14. 9663584 - Antibodies to non-functional P2X7 receptor (2017-05-30),

15. 9566318 - Combination therapy (2017-02-14),

Biosceptre (Aust) Pty Ltd is an innovative biotechnology company based in North Ryde, Australia, specializing in the development of advanced therapeutic solutions. The organization focuses on harnessing proprietary technologies to create novel treatments, particularly in the field of cancer immunotherapy. With a commitment to addressing unmet medical needs, Biosceptre aims to improve patient outcomes through its cutting-edge research and development efforts in the biopharmaceutical sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

17 Patents

#5 in North Ryde

#212 in Australia

#35,857 in the World

North Ryde, Australia

Biosceptre (Aust) Pty Ltd

Forward Citations = 51

10 inventors:

Julian Alexander Barden (16 out of 32 patents)

Angus Gidley-Baird (10 out of 25 patents)

Philip Jones (4 out of 13 patents)

4. Neil Brewis (4 out of 5 patents)

5. Steven Grant (4 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…